Koyfin Home > Directory > Health Care > Aduro Biotech > Long-Term Debt / Capital

Aduro Biotech Long-Term Debt / Capital Chart (ADRO)

Aduro Biotech annual/quarterly Long-Term Debt / Capital from 2013 to 2020.
  • Aduro Biotech Long-Term Debt / Capital for the quarter ending June 06, 2020 was $39m a 28.83% increase of 11m year over year
  • Aduro Biotech Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $39m a 28.83% increase of 11m year over year
  • Aduro Biotech Annual Long-Term Debt / Capital for 2019 was $32m a 32.57% increase of 10m from 2018
  • Aduro Biotech Annual Long-Term Debt / Capital for 2013 was $22m a -1,399.20% decrease of -301m from 2012
  • Aduro Biotech Annual Long-Term Debt / Capital for 2012 was $323m
Other Ratios Metrics:
  • Aduro Biotech Total Debt / Capital for the quarter ending September 09, 2014 was $4m
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Debt / Equity for the quarter ending September 09, 2014 was $4m
View Chart On Koyfin

Quarterly ADRO Long-Term Debt / Capital Data

06/2020$39m
03/2020$34m
12/2019$32m
09/2019$28m
06/2019$24m
03/2019$22m
09/2014$3m
12/2013$22m

Annual ADRO Long-Term Debt / Capital Data

2019$32m
2013$22m
2012$323m